Huzhou Puyuan Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Huzhou Puyuan Biotechnology Co., Ltd. - overview
Established
2021
Location
Huzhou, Zhejiang, China
Primary Industry
Medical Devices & Equipment
About
Based in Shanghai, China and established in 2021, Huzhou Puyuan Biotechnology Co. , Ltd. operates as a medical equipment developer that focuses on MALDI-TOF MS automatic instruments R&D. Zhenhua Wang is the CEO of the company.
The company provides matrix-assisted laser desorption / ionization time of flight mass spectrometry (MALDI-TOF MS) automatic instruments, equipment, consumables and solutions for many fields, such as clinical medicine, inspection and quarantine, food safety, disease control. The company develops microbial mass spectrometry system, nucleic acid mass spectrometry system, rapid detection system of foodborne pathogenic bacteria technologies. The company's products include automatic MALDI-TOF MS, microbial identification and nucleic acid detection chip. The company's equipment includes intelligent basic manufacturing equipment, mechanical and electrical equipment, electronic components and electromechanical component equipment.
In July 2022, the company will plan to construct research and development base, promote product.
Current Investors
Pure Funds
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Healthcare IT, Medical Devices & Equipment, Electronics
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.